Refine your search
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Srinivasulu, P.
- Secured Rekeying in B-Tree and NSBHO Tree
Abstract Views :123 |
PDF Views:0
Authors
Affiliations
1 Department of Computer Science and Engineering, V.R.Siddhartha Engineering College, Vijayawada, IN
1 Department of Computer Science and Engineering, V.R.Siddhartha Engineering College, Vijayawada, IN
Source
International Journal of Advanced Networking and Applications, Vol 1, No 2 (2009), Pagination: 131-140Abstract
Many emerging Web and Internet applications are based on a group communication model. Securing group communication is an important Internet design issue. A Key Graph approach has been used to implement the group key management and it is used to provide secure group communication. The group key management can be done in two ways: 1. Individual rekeying 2. Batch rekeying. Individual Rekeying is the process of rekeying after each join or leave request. The problem with individual rekeying is inefficiency and out-of-sync problem between keys and data. A batch rekeying using MARKING ALGORITHM can overcome the problems faced in the individual rekeying. The paper applies Batch rekeying by Marking Algorithm on the B-Tree (2-3 trees) and NSBHO (Non Splitting Balancing Higher Order) tree. The Analyzing done on the key server’s processing cost for batch rekeying in B-Tree and NSBHO tree. The proposed NSBHO (Non-Split Balancing High-Order) tree in which balancing tree after member joining does not involve node splitting. The implementation shows that the NSBHO tree has better average-case rekeying performance and far superior worst-case rekeying performance than a B-tree.Keywords
Balanced Tree, Dynamic Group, Group Key Management, High-Order Tree, Secure Multicast.- Network Intrusion Detection Using FP Tree Rules
Abstract Views :114 |
PDF Views:0
Authors
Affiliations
1 Department of Computer Science and Engineering, V R Siddhartha Engineering College, Vijayawada, IN
2 Department of Computer Science and Engineering, Acharya Nagarjuna University, Guntur, IN
1 Department of Computer Science and Engineering, V R Siddhartha Engineering College, Vijayawada, IN
2 Department of Computer Science and Engineering, Acharya Nagarjuna University, Guntur, IN
Source
International Journal of Advanced Networking and Applications, Vol 1, No 1 (2009), Pagination: 30-39Abstract
In the faceless world of the Internet, online fraud is one of the greatest reasons of loss for web merchants. Advanced solutions are needed to protect e-businesses from the constant problems of fraud. Many popular fraud detection algorithms require supervised training, which needs human intervention to prepare training cases. Since it is quite often for an online transaction database to have Terabyte-level storage, human investigation to identify fraudulent transactions is very costly. This paper describes the automatic design of user profiling method for the purpose of fraud detection. We use a FP (Frequent Pattern) Tree rule-learning algorithm to adaptively profile legitimate customer behavior in a transaction database. Then the incoming transactions are compared against the user profile to uncover the anomalies. The anomaly outputs are used as input to an accumulation system for combining evidence to generate high-confidence fraud alert value. Favorable experimental results are presented.Keywords
Fraud Detection, FP Tree, Anomalies, Adaptive Mining, Association Mining.- Effect of Candesartan Cilexetil on the Blood Glucose Levels of Glimepiride in Normal and Diabetic Albino Rats
Abstract Views :492 |
PDF Views:90
Authors
Affiliations
1 Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Guntur, A.P, IN
1 Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Guntur, A.P, IN
Source
Journal of Pharmaceutical Research, Vol 17, No 2 (2018), Pagination: 57-66Abstract
Background: Co administration of two or more medications to a patient is called polypharmacy. Hence, much attention is required to study the possible drug interaction in the prescription, to reduce the influence of one drug action on the another. Accordingly, the effect of candesartan cilexetil was studied on the blood glucose levels of glimepiride treated normal and diabetic rats. Method: Effect of blood glucose levels were studied by using Candesartan cilexetil and Glimepiride in normal and diabetic albino male rats at a dose of 1.44 mg/kg and 0.09 mg/kg, respectively. The blood samples were collected during the study at the time intervals of 0, 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 24 hours. The samples were subjected to estimation of blood glucose levels using glucometer. Results: The present study was conducted in both normal and diabetic rats. Glimepiride showed its hypoglycemic effect at the 4th hour, whereas candesartan cilexetil doesn’t show any changes in blood glucose levels in both normal and diabetic rats. In normal rats, candesartan cilexetil doesn’t affect on the blood glucose levels of glimepiride in both single and multiple dose studies. In diabetic rats, the candesartan cilexetil showed significant action on blood glucose levels of glimepiride in multiple dose interaction study but the insignificant effect of candesartan cilexetil in single dose interaction on glimepiride. Hence, the interaction was carefully monitored in type-2 diabetes mellitus patients. Conclusion: The study suggested that candesartan cilexetil has a profound effect on blood glucose levels of glimepiride on long term use; the possible mechanism for the cause is either angiotensin converting enzyme inhibitors improve insulin sensitivity or inhibition of CYP2C9. The study also recommended that caution must be taken while prescribing with the combination of candesartan cilexetil and glimepiride or its analogs.Keywords
Diabetes, Polypharmacy, Blood Glucose Levels, Candesartan Cilexetil, Glimepiride, Albino Male Rats.References
- Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. The American journal of geriatric pharmacotherapy. 2007 Dec 1; 5(4):345-51.
- Prescott LF. Clinically important drug interactions. Drugs. 1973 Mar 1; 5(3):161-86.
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014 Jan 1; 37 (Supplement 1):S81-90.
- Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Annals of internal medicine. 2003 Nov 4; 139 (9):761-76.
- Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992 May 1; 19(5):403-18.
- Sowers JR, Epstein M. Diabetes mellitus and hypertension, emerging therapeutic perspectives. Cardiovascular Therapeutics. 1995 Jun 1;13 (2):149-210.
- Solini A, DeFronzo RA. Hypertension, cardiovascular disease, diabetes mellitus, and diabetic nephropathy: role of insulin resistance. InThe Kidney and Hypertension in Diabetes Mellitus 1996 (pp. 61-74). Springer US.
- Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB. Cytochrome P450 2C9-CYP2C9. Pharmacogenetics and genomics. 2010 Apr;20(4):277.
- Murakami H, Yabusaki Y, Ohkawa H. Expression of rat NADPH-cytochrome P-450 reductase cDNA in Saccharomyces cerevisiae. DNA. 1986 Feb;5(1):1-0.
- Holstein A, Beil W, Kovacs P. CYP2C metabolism of oral antidiabetic drugs-impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. Expert opinion on drug metabolism & toxicology. 2012 Dec 1;8 (12):1549-63.
- Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of basic and clinical pharmacy. 2016 Mar;7(2):27.
- Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabetic medicine. 2005 Apr 1; 22(4):359-70.
- Etuk EU. Animals models for studying diabetes mellitus. Agric Biol JN Am. 2010;1(2):130-4.
- Ghosh M. Fundamentals of Experimental Pharmacology Hilton and Company. Kolkata, India. 2005.
- Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J. Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes. Diabetes Care. 2002 Sep 1;25 (9):1607-11.
- Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Diabetes care. 2005 Dec 1;28(12):2948-61.
- Prasad A, Quyyumi AA. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation. 2004 Sep 14;110 (11):1507-12.
- Kurtz TW, Pravenec M. Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system. Journal of hypertension. 2004 Dec 1;22(12):2253-61.
- Higashiura K, Ura N, Takada T, Li Y, Torii T, Togashi N, Takada M, Takizawa H, Shimamoto K. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
- Onuchin SG, Elsukova OS, Onuchina EL. Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome. Klinicheskaia meditsina. 2007 Dec;86 (8):61-6.
- Srivastava RA. Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11β-HSD1, PEPCK and DGAT2: Comparison of PPARα, PPARγ, and liver x receptor agonists. European journal of pharmacology. 2009 Apr 1;607(1):258-63.
- Murayama S, Hirano T, Sakaue T, Okada K, Ikejiri R, Adachi M. Low-dose candesartan cilexetil prevents early kidney damage in type 2 diabetic patients with mildly elevated blood pressure. Hypertension Research. 2003;26(6):453-8.
- Rosei EA, Rizzoni D, Muiesan ML, Sleiman I, Salvetti M, Monteduro C, Porteri E, CENTRO (CandEsartaN on aTherosclerotic Risk factors) Study Investigators. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. Journal of hypertension. 2005 Feb 1; 23(2):435-44.
- Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N, DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. The Lancet. 2008 Oct 24; 372 (9647):1385-93.
- DIRECT Programme Study Group, Chaturvedi N. The Diabetic Retinopathy Candesartan Trials (DIRECT) programme, rationale and study design. Journal of the Renin-Angiotensin-Aldosterone System. 2002 Dec; 3(4):255-61.
- DIRECT Programme Study Group. The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics. Journal of the Renin-AngiotensinAldosterone System. 2005 Mar; 6(1):25-32.
- Grassi G, Seravalle G, Dell’Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. Journal of hypertension. 2003 Sep 1; 21 (9):1761-9.
- Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes. 2006 Feb 1; 55 (2):367-74.
- Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, Karalliedde J, Viberti G, Jones PM, Persaud SJ. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia. 2006 Feb 1; 49(2):321-31.
- Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia. 2004 Feb 1; 47(2):240-8.
- Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes. 2004 Apr 1;53(4):989-97.
- Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 1. A meta-analysis of randomised clinical trials. Diabetes & metabolism. 2004 Dec 1; 30(6):487-96.
- Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin–angiotensin system reduces the incidence of new-onset diabetes. Journal of hypertension. 2005 Mar 1; 23(3):463-73.
- Putnam K, Shoemaker R, Yiannikouris F, Cassis LA. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology. 2012 Mar 15; 302 (6):H1219-30.
- Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Drugs. 2004 Nov 1; 64 (22):2537-65.
- An Overview of AVIRIS-NG Airborne Hyperspectral Science Campaign Over India
Abstract Views :252 |
PDF Views:85
Authors
Bimal K. Bhattacharya
1,
Robert O. Green
2,
Sadasiva Rao
3,
M. Saxena
1,
Shweta Sharma
1,
K. Ajay Kumar
1,
P. Srinivasulu
3,
Shashikant Sharma
1,
D. Dhar
1,
S. Bandyopadhyay
4,
Shantanu Bhatwadekar
4,
Raj Kumar
1
Affiliations
1 Space Applications Centre, Indian Space Research Organisation, Ahmedabad 380 015, IN
2 Jet Propulsion Laboratory, California Institute of Technology, CA 91109, IN
3 National Remote Sensing Centre, Indian Space Research Organisation, Hyderabad 500 625, IN
4 Earth Observation Science Directorate, Indian Space Research Organisation, Bengaluru 560 231, IN
1 Space Applications Centre, Indian Space Research Organisation, Ahmedabad 380 015, IN
2 Jet Propulsion Laboratory, California Institute of Technology, CA 91109, IN
3 National Remote Sensing Centre, Indian Space Research Organisation, Hyderabad 500 625, IN
4 Earth Observation Science Directorate, Indian Space Research Organisation, Bengaluru 560 231, IN
Source
Current Science, Vol 116, No 7 (2019), Pagination: 1082-1088Abstract
The first phase of an airborne science campaign has been carried out with the Airborne Visible/Infrared Imaging Spectrometer Next Generation (AVIRIS-NG) imaging spectrometer over 22,840 sq. km across 57 sites in India during 84 days from 16 December 2015 to 6 March 2016. This campaign was organized under the Indian Space Research Organisation (ISRO) and National Aeronautics and Space Administration (NASA) joint initiative for HYperSpectral Imaging (HYSI) programme. To support the campaign, synchronous field campaigns and ground measurements were also carried out over these sites spanning themes related to crop, soil, forest, geology, coastal, ocean, river water, snow, urban, etc. AVIRIS-NG measures the spectral range from 380 to 2510 nm at 5 nm sampling with a ground sampling distance ranging from 4 to 8 m and flight altitude of 4–8 km. On-board and ground-based calibration and processing were carried out to generate level 0 (L0) and level 1 (L1) products respectively. An atmospheric correction scheme has been developed to convert the measured radiances to surface reflectance (level 2). These spectroscopic signatures are intended to discriminate surface types and retrieve physical and compositional parameters for the study of terrestrial, aquatic and atmospheric properties. The results from this campaign will support a range of objectives, including demonstration of advanced applications for societal benefits, validation of models/techniques, development of state-of-the-art spectral libraries, testing and refinement of automated tools for users, and definition of requirements for future space-based missions that can provide this class of measurements routinely for a range of important applications.Keywords
Airborne Science Campaign, Hyperspectral Sensing, Imaging Spectrometer, Surface Reflectance.References
- Bhattacharya, B. K. and Chattopadhyay, C., A multi-stage tracking for mustard rot disease combining surface meteorology and satellite remote sensing. Comput. Electron. Agric., 2013, 90, 35– 44.
- Bhattacharya, S., Majumdar, T. J., Rajawat, A. S., Panigrahy, M. K. and Das, P. R., Utilization of Hyperion data over Dongargarh, India, for mapping altered/weathered and clay minerals along with field spectral measurements. Int. J. Remote Sensing, 2012, 33(17), 5438–5450.
- Ramakrishnan, D. and Bharti, R., Hyperspectral remote sensing and geological applications. Curr. Sci., 2015, 108(5), 879–891.
- Sahoo, R. N., Ray, S. S. and Manjunath, K. R., Hyperspectral remote sensing of agriculture. Curr. Sci., 2015, 108(5), 848–859.
- Das, B. S., Sarathjith, M. C., Santra, P., Sahoo, R. N., Srivastava, R., Routray, A. and Ray, S. S., Hyperspectral remote sensing: opportunities, status and challenges for rapid soil assessment in India. Curr. Sci., 2015, 108(5), 860–868.
- Ramakrishnan, D. and Sahoo, R. N., Network Programme on Imaging Spectroscopy and Applications (NISA): science plan and implementation strategy. Department of Science and Technology, Government of India, 2016.
- Ajay Kumar, K., Thap, N. A. and Kuriakose, S. A., Advances in spaceborne hyperspectral imaging systems. Curr. Sci., 2015, 108(5), 826–832.
- Green, R. O. et al., Imaging spectroscopy and the airborne visible/ infrared imaging spectrometer (AVIRIS). Remote Sensing Environ., 1998, 65(3), 227–248.
- Green, R. O. et al., The Moon Mineralogy Mapper (M3) imaging spectrometer for lunar science: instrument description, calibration, on-orbit measurements, science data calibration and on-orbit validation. J. Geophys. Res.: Planets, 2012, 116(E10).
- Anonymous, Thriving on Our Changing Planet: A Decadal Strategy for Earth Observation from Space, 2017–2027 Decadal Survey for Earth science and applications from space. The National Academies of Science, Engineering and Medicine (ISBN 978-0-30946757-5). The National Academies Press, Washington, DC, USA, 2017; doi:10.17226/24938.